Prevention

The proximity of sinks in patient zones may increase a patient’s risk of acquiring gram-negative hospital-acquired infections.

What do infection prevention and control personnel need to know about preparing for future pandemics? Maureen Hennessey, PhD, CPCC, CPHQ, SVP, and Cynthia Miller, MD, MPH, discuss their thoughts with ICT.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending March 5, 2023.

As the third year of COVID-19 begins, some questions have been answered, but others still remain. ICT asked leaders in the infection prevention and control field what answers the medical world needs now.

Information presented at this week's Congressional Committee needs a much deeper evaluation and consideration. The Cochrane Masking study may even vindicate the federal government's initial COVID-19 response.

Identifying the categories patients with staphylococcus aureus bacteremia fit into is in order to better care for them.

Week of March 1, 2023, Saskia v. Popescu, PhD, MPH, MA, CIC, discusses the hottest topics in infection prevention and control. This week it is the Marburg Virus, COVID-19 origins, and avian (bird) flu.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending February 24, 2023.

Specifically for older individuals and immunocompromised individuals, a year could be too long.

Post-COVID-19 immune dysfunction is supported by epidemiological, clinical, and laboratory evidence. Attributing, with little to no evidence, that masking and lack of exposure is the primary driver of increases in bacterial and viral infections discourages critical interventions needed to stop the spread of disease.

Mpox (formerly “monkeypox”) is endemic in certain African countries but was rarely reported in the Western world until recently.

The Conference on Retroviruses and Opportunistic Infections 2023 has research in COVID-19, mpox, hepatitis, and other viral infections, plus networking, and even Anthony Fauci, MD, speaking on his legacy.

Catching COVID-19 to prevent a more severe case is not a good strategy, says Kevin Kavanagh, MD.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending February 17, 2023.

COVID-19 reinfection chances vary to variant and time since the previous infection, according to a new study.

What can the media do to better cover the "tripledemic," and where are all the advocacy groups for these infectious diseases?

The triple epidemic or “tripledemic” of influenza, COVID-19, and respiratory syncytial virus (RSV) may have peaked. What caused the confluence of these viruses to start, and how can we stop it from happening again?

These treatments were reviewed in a real-world application to evaluate their effectiveness in preventing recurrences.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending February 10, 2023.

Saskia v. Popescu, PhD, MPH, MA, CIC, discusses the latest in the artificial tears infection alert and in the bird flu—and good news for COVID-19—for February 10, 2023.

Experts from around the world shared new data about cryptococcus at the recent International Conference on Cryptococcus & Cryptococcosis (ICCC) in Uganda.

A new study shows antibiotics are not the only widely used pharmaceuticals that can induce the emergence of treatment-resistant bacteria.

What should individuals getting a tattoo look for to protect themselves from infection?

Can a patient catch C difficile if the previous hospital room occupant had it?

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending February 3, 2023.

Could live attenuated vaccines and intranasal vaccines be the answer for RSV, COVID-19, and even cancer tumors?

Rodents are known to transmit more than 35 illnesses. What signs should environmental services personnel and infection preventionists look for?

How can food service and health care workers prevent the spread of norovirus? Keeping employees at home, using the correct products the right way, and more.

Are norovirus cases going to skyrocket, or will the pandemic slowdown of this infectious disease continue?

The FDA's Vaccines and Related Biological Products Advisory Committee laid out a simpler direction for SARS-CoV-2 development and deployment.